These findings suggest that not all patients may benefit from GLP-1 RAs in terms of weight loss, especially those whose obesity and WR are strongly linked to emotional factors, which may reduce sensitivity to physiological satiety signals. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.